DexCom Inc (NAS:DXCM)
$ 78.93 -1.54 (-1.91%) Market Cap: 31.43 Bil Enterprise Value: 31.12 Bil PE Ratio: 48.19 PB Ratio: 15.87 GF Score: 79/100

Q3 2024 Dexcom Inc Earnings Call Transcript

Oct 24, 2024 / 08:30PM GMT
Release Date Price: $74.85 (+3.27%)
Operator

Thanks or Ladies and gentlemen, welcome to the DexCom Third Quarter 2024 earnings release conference call.

My name is Abby, and that will be your operator for today's call.

At this time, all participants are in a listen-only mode and later we will conduct a question and answer session.

During the question and answer session.

If you have a question, please press star one on your touch-tone phone.

As a reminder, the conference is being recorded.

And I will now turn the call over to Sean Christensen, Vice President, Finance and Investor Relations.

Sean Christensen
Dexcom Inc - VP, Finance and IR

Mr. Christian, you may begin for you and welcome to DexCom's Third Quarter 2024 earnings call.

Our agenda begins with Kevin Sayer, DexCom's Chairman, President and CEO, who will summarize our recent highlights and ongoing strategic initiatives, followed by a financial review and outlook from Jeremy Sylvain, our Chief Financial Officer.

Following our prepared remarks, we will open the call up

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot